Ethocybin
Ethocybin (also known as CEY-19 and Cyanescens ethocybin) is a psychedelic and entheogenic alkaloid of the tryptamine class. It is found in certain species of Psilocybe, a genus of mushrooms, specifically Psilocybe cyanescens. Ethocybin was first isolated from these mushrooms by chemists at Sandoz in the 1960s.
Chemistry[edit]
Ethocybin is a member of the tryptamine class of alkaloids, which also includes other psychedelic substances such as psilocybin, psilocin, and DMT. It is structurally similar to psilocybin, with the only difference being the ethyl group in ethocybin instead of the methyl group in psilocybin. This structural similarity is responsible for the similar psychedelic effects of the two substances.
Pharmacology[edit]
Like other tryptamines, ethocybin acts primarily as a serotonin receptor agonist. It is thought to affect the 5-HT2A receptor, which is involved in regulating mood, anxiety, and perception. The exact mechanism of action is not fully understood, but it is believed to involve a complex interplay of neurochemical and psychological processes.
Effects[edit]
The effects of ethocybin are similar to those of other psychedelic tryptamines. They can include visual and auditory hallucinations, changes in perception of time and space, altered thought processes, and heightened emotional sensitivity. The intensity and duration of these effects can vary depending on the dose and individual's physiology and psychology.
Legal Status[edit]
The legal status of ethocybin varies by country. In many places, it is classified as a Schedule I drug, meaning it is considered to have a high potential for abuse and no accepted medical use. However, research into the potential therapeutic uses of ethocybin and other psychedelics is ongoing.
See Also[edit]
-
Ethocybin
-
Ethocybin zwitterion 3D ball
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
